Skip to main content
RHYTHM PHARMACEUTICALS, INC. logo

RHYTHM PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · RYTM ISIN · US76243J1051 LEI · 529900JPNWXQ8DPLA551 US Manufacturing
Open in API
Filings indexed 775 across all filing types
Latest filing 2017-10-24 Major Shareholding Noti…
Country US United States of America
Listing US RYTM

About RHYTHM PHARMACEUTICALS, INC.

https://rhythmtx.com/

Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on developing and commercializing precision medicines for rare genetic diseases of obesity. The company's work centers on the melanocortin-4 receptor (MC4R) pathway, a key biological system that regulates hunger and energy expenditure. Its lead product, IMCIVREE® (setmelanotide), is an MC4R agonist approved for treating severe obesity and hyperphagia (insatiable hunger) in patients with specific rare conditions, such as Bardet-Biedl syndrome. Rhythm is dedicated to advancing a portfolio of therapies that address the root cause of rare neuroendocrine diseases to improve patient outcomes.

Recent filings

Filing Released Lang Actions
SC 13D
Major Shareholding Notification
2017-10-24 English
SCHEDULE 13D
Major Shareholding Notification
2017-10-20 English
SCHEDULE 13G
Major Shareholding Notification
2017-10-18 English
NEW ENTERPRISE ASSOCIATES 13, L.P. - RHYTHM PHARMACEUTICALS, INC. 13D
Major Shareholding Notification
2017-10-13 English
4
Director's Dealing
2017-10-12 English
S-8
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC by Rhythm Pharmaceuticals, Inc. It relates to the registration of securities under the Securities Act of 1933, specifically for the 2017 Equity Incentive Plan and the 2017 Employee Stock Purchase Plan. The content includes details about the securities to be registered, calculation of registration fees, incorporation by reference of other filings, indemnification of directors and officers, and undertakings related to the registration. This type of filing is a registration statement for employee benefit plans and stock incentive plans, which is a capital/financing related filing rather than a financial report, management information, or other categories. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is the actual registration statement, not just an announcement or certification.
2017-10-12 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.